GlassScriptPhysician profile
Andrea L Smith
NPI 1841383619
$897.96
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $551 · 2021: $135 · 2022: $15.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $323.52 | 2019-2020 | |
| Pfizer INC. | $107.46 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $68.70 | 2019 | |
| Lilly USA, LLC | $68.18 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $65.93 | 2019-2021 | |
| Amarin Pharma, INC. | $57.38 | 2020 | |
| Novo Nordisk INC | $38.52 | 2019-2021 | |
| Global Blood Therapeutics, INC. | $34.58 | 2020 | |
| Eisai INC. | $24.03 | 2019 | |
| Abbott Laboratories | $21.21 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.39 | 2019 | |
| Acacia Pharma INC | $15.72 | 2022 | |
| Allergan, INC. | $15.65 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.